Skip to content
Guides · Billing

Brasíndice and Simpro: how to price supplies and drugs on the claim

Two private price references adopted in Brazilian hospital contracts. How the price publications work, what the contract defines and the pricing errors to avoid.

By Published on 8 min read

What are Brasíndice and Simpro?

Brasíndice and Simpro are private publications that compile prices for drugs and health products in Brazil. Hospitals and health plans (operadoras) use them as market references to value items on the hospital claim. Neither is a government table: they only apply to the claim when the contract between hospital and health plan adopts them. The closest US analogy is a mix of a chargemaster and drug pricing compendia, but the logic is different: the price is set by contract over a third-party publication.

Simpro publishes the Revista Simpro Hospitalar, which the publisher presents as a maximum-price reference for drugs and health products, used in billing, claim review, quotes and tenders [2]. According to the publisher, the information is the sole responsibility of the advertisers (manufacturers, importers and distributors), with no influence from the magazine on how prices are set [2]. For products, it lists the factory price current at the date of the latest survey; for drugs, prices come from company price lists and are compared with those published by Anvisa (the health regulatory agency) [2]. Each edition states its validity period [2].

Brasíndice is another private price publication that contracts may adopt as a reference.

This guide is part of the Hospital billing topic: supplies and drugs are one of the claim lines that weigh most on revenue.

Code, ceiling and reference: three different things

Pricing an item on the claim involves three layers, each with its own owner.

LayerWho defines itWhat it providesWhat it does not provide
Code (TUSS)ANS (the National Supplementary Health Agency), sourced from Anvisa and, for drugs, also CMED [3]Table 19 (supplies and OPME) and table 20 (drugs); code, term, description and validity [3]Price: a TUSS term has no value field [3]
Regulated ceilingCMED (Law 10,742/2003) [6]Drug PF and PMC, with annual adjustment [5][6]Supply prices; contract markup
Market referencePrivate publisher (Brasíndice, Simpro) or the parties (own schedule)Price per item and presentation, per editionThe application rule: the contract decides

In practice, a hospital can have the right TUSS code (Unified Terminology for Supplementary Health) and the right magazine price and still bill wrong, because it applied the wrong contract rule. The TUSS code table guide explains how to look up codes.

PF and PMC: which price applies to drugs?

CMED Resolution 3/2009 (Resolução CMED nº 3/2009) defines the Manufacturer Price (PF) as the ceiling at which a laboratory or distributor may sell a drug in Brazil, and the Maximum Consumer Price (PMC) as the retail ceiling, that is, pharmacies and drugstores [5]. CMED was created by Law 10,742/2003, which set the ceiling model with annual adjustment [6].

Article 3 of the same resolution prohibits publishing a PMC, in any medium, for a drug whose registration defines it as restricted to hospitals and clinics [5].

The effect on the claim: if the contract says all drugs are billed “at PMC”, there will be no published PMC for hospital-only drugs. Without a written rule for that group, each side applies its own reading and the item tends to become a dispute. The fix is for the contract to state, by group, which ceiling applies and what to do when it does not exist (for example, PF plus a defined percentage).

What the contract needs to define

Law 9,656/1998, art. 17-A, § 2, II, requires the contract between health plan and provider to state service values, adjustment and billing and payment deadlines [4]. For supplies and drugs, “value” may not be a fixed number but a rule that points to a publication. That rule must answer seven questions.

DecisionQuestionExample wording to record
1. PublicationWhich reference applies to each group?Brasíndice for drugs, Simpro for supplies, own list for diets and gases
2. Edition and base dateWhich edition applies to the claim?The one valid on the date of service (or discharge, or submission); deadline to adopt a new edition
3. Price typePF, PMC or product factory price?PF for all drugs; specific rule for hospital-only drugs with no PMC [5]
4. Discount or markupWhat percentage applies to the reference?Discount or markup by group, with validity and adjustment rule
5. FractioningBill the fraction used or the whole package?Fraction for multidose vials; package for single-use items
6. Unit of measureIn which unit is the item billed?Same unit as the adopted publication; defined conversion for tablet, ampoule, mL
7. Own schedule and unlisted itemsWhat applies to items not in the reference?Own list attached and versioned; substitute reference or quote with invoice

Two notes. Contract adjustment and a new magazine edition are different events, and both must be in the master data with dates. And items included in fees, bundles or the procedure should not be priced separately: their composition must be attached to the contract. The Hospital–health plan contract guide covers the other clauses.

From item to claim line: the five decisions that set the price From item to claim line: the five decisions that set the price 1. Item Usage record prescription, check OR sheet 2. Code TUSS (ANS) table 19 supplies table 20 drugs 3. Reference Publication + edition Brasíndice, Simpro or own schedule 4. Rule Set in the contract PF or PMC · discount fraction · unit 5. Claim line TISS form table · code · qty unit and total value Sources: ANS — TISS 202609; Law 9,656/1998, art. 17-A; CMED Resolution 3/2009; Simpro (10/17/2026)
Sources: ANS — TISS Standard 202609; Law 9,656/1998, art. 17-A; CMED Resolution 3/2009; Simpro (10/17/2026) · the five decisions that set the price of a supply or drug on the claim. Produced by Accrua.
See the steps as a list
  1. Item — usage record (prescription, nursing check, OR sheet)
  2. Code — ANS TUSS: table 19 (supplies) or 20 (drugs)
  3. Reference — publication and edition: Brasíndice, Simpro or the health plan's own schedule
  4. Rule — set in the contract: PF or PMC, discount or markup, fractioning, unit
  5. Claim line — TISS form: table code, item code, quantity, unit and total value

How the price becomes a TISS claim line

On a claim sent under the TISS standard (the ANS electronic data interchange standard), each supply or drug is a line with, among other fields, the reference table code, the item code, quantity, unit of measure and values..

The table code tells where the item code comes from: 19 for supplies, 20 for drugs, or a health plan's own table. TISS allows own code tables (tables 00, 90 and 98, up to 10 characters) for terms not yet in TUSS, but forbids keeping them once the term enters TUSS and the implementation deadline passes [3]. In TUSS version 202607, table 87 (domain tables) lists 00 “Tabela própria das operadoras” (health plan's own table), 90 “Tabela Própria Pacote Odontológico” (own dental package table) and 98 “Tabela Própria de Pacotes” (own package table), plus 18, 19, 20 and 22 for TUSS terms; the unit of measure follows table 60, such as 001 (AMP, ampoule) [7].

Note the two kinds of “own table”. An own price schedule is the list of values negotiated in the contract instead of a publication. An own code table is the health plan's coding for items with no TUSS code. One does not imply the other: an item can have a TUSS code and an own-schedule price.

The TISS claim forms guide explains which form each item goes on.

Pricing errors to avoid

These errors come from master data and calculation rules, and all can be caught before submission. The denial codes each one may trigger are in the Supplies and drug denials guide.

ErrorHow it happensPrevention
Outdated or early editionMaster data switches edition on a date other than the contract ruleBase date written in the contract; edition history in the system
Wrong ceilingDrug valued at PMC when the contract says PF, or vice versaRule by group, including hospital-only drugs
Another contract's percentageOne plan's discount or markup applied to anotherPercentage by health plan, group and validity
Package instead of fractionWhole vial billed when the contract pays the doseFractioning rule in contract and master data
Unit mismatchPublication price per box, quantity entered per unitUnit conversion per item
Wrong presentationPrice of another strength or manufacturerLink stock item ↔ presentation in the publication
Unlisted itemItem missing from own schedule, billed at a loose priceClause with substitute reference or quote
OPME priced as a regular supplySpecial device billed under supply rulesClassification checked by the OPME team (see OPME denials)

Who owns pricing in the hospital?

Supply and drug pricing spans three areas. Procurement and pharmacy keep the link between stock item and publication presentation. Contracts translate each clause into parameters (publication, edition, ceiling, percentage). Billing checks the claim before submission. When no one owns the edition switch, it may happen too late or too early.

What we see in operations

At Accrua, the price of every supply and drug is checked against the contract, not against the reference publication on its own. Accrua OS has, per health plan, the contracted table, the pricing rule (PF, PMC or the plan's own table), the edition of the reference that applies to that contract and the denial history for that item. Before submission, every line of the claim is checked against those rules.

The alerts that matter most come up when the hospital's item master uses a different edition from the one in the contract, when the pricing rule applied is not the one agreed, or when a hospital-only drug is billed at a price that does not apply to it. Correcting an item that changes the value is the biller's or auditor's decision, with the clause in view.

When the same gap keeps coming back, the fix goes to the source: the hospital's price master, or the clause the hospital can take to its next negotiation.

Where to start

  1. List your contracts and answer the seven decisions in the table above for each. A gap is a clause to negotiate.
  2. Set up the system with publication, edition, ceiling and percentage by health plan and group, always with validity dates.
  3. Link each stock item to the presentation and unit in the adopted publication.
  4. Name an owner for the edition switch and the date it enters master data.
  5. Check claims before submission with rules for prices above the reference and for unlisted items.

Frequently asked questions about Brasíndice and Simpro

Are Brasíndice and Simpro official tables?

No. They are private price publications. They apply to the claim when the contract adopts them, with the price type, edition and percentage the contract defines. The regulated drug ceiling is CMED's, and the item code is TUSS, from ANS.

What is the difference between PF and PMC?

PF is the ceiling for sales by laboratories or distributors; PMC is the retail ceiling (pharmacies and drugstores), under CMED Resolution 3/2009.

Why do some drugs have no PMC?

Because CMED Resolution 3/2009 prohibits publishing a PMC for drugs restricted to hospitals and clinics. The contract needs a rule for these items.

Which magazine edition applies to the claim?

The one the contract defines. It may be the date of service, discharge or submission. Without a clause, the mismatch can become a denial.

Can a health plan's own schedule replace Brasíndice and Simpro?

Yes, if the contract says so. The list must then be attached and versioned, with a rule for items not on it.

Sources

  1. Anahp — Observatório Anahp 2025 (2024 data), Table 3 (gross revenue by type); 119 reporting hospitals.
  2. Simpro — Revista Simpro Hospitalar, publisher's official page, accessed 10/17/2026.
  3. ANS — Padrão TISS: Componente Organizacional (TISS Standard: Organizational Component), version 202609 (September 2026), items 70, 82–94 and 112–116.
  4. Presidency of the Republic — Lei nº 9.656/1998 (Law 9,656/1998), art. 17-A, § 2, II (consolidated text).
  5. CMED — Resolução nº 3, de 4 de maio de 2009 (Resolution 3 of May 4, 2009), arts. 1–3, published in the Ministry of Health Health Price Bank.
  6. Presidency of the Republic — Lei nº 10.742/2003 (Law 10,742/2003, pharmaceutical sector regulation and creation of CMED), arts. 4–6.
  7. ANS — TUSS, tables 87 (domain tables) and 60 (unit of measure), version 202607, official ANS “Demais terminologias” spreadsheet, checked on 10/18/2026.